CORTESI PAOLO ANGELO

Antonazzo, I., Rozza, D., Conti, S., Fornari, C., Cortesi, P., Eteve-Pitsaer, C., et al. (2024). Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database. EUROPEAN JOURNAL OF NEUROLOGY, 31(1 (January 2024)) [10.1111/ene.16064]. Detail

Fornari, A., Antonazzo, I., Rocino, A., Preti, D., Fragomeno, A., Cucuzza, F., et al. (2024). The psychosocial impact of haemophilia from patients’ and caregivers’ point of view: The results of an Italian survey. HAEMOPHILIA, 30(2), 449-462 [10.1111/hae.14926]. Detail

Cortesi, P., Antonazzo, I., Palladino, P., Gnesi, M., Mele, S., D’Amelio, M., et al. (2024). Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis. ACTA DIABETOLOGICA [10.1007/s00592-024-02276-3]. Detail

Brauer, M., Roth, G., Aravkin, A., Zheng, P., Abate, K., Abate, Y., et al. (2024). Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. THE LANCET, 403(10440 (18–24 May 2024)), 2162-2203 [10.1016/s0140-6736(24)00933-4]. Detail

Antonazzo, I., Gribaudo, G., La Vecchia, A., Ferrara, P., Piraino, A., Cortesi, P., et al. (2024). Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review. PHARMACOECONOMICS [10.1007/s40273-024-01428-1]. Detail